• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN LAP-BAND AP ADJUSTABLE GASTRIC BANDING SYSTEM (STANDARD)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN LAP-BAND AP ADJUSTABLE GASTRIC BANDING SYSTEM (STANDARD) Back to Search Results
Catalog Number B-2240
Device Problems Fluid/Blood Leak (1250); Appropriate Term/Code Not Available (3191)
Patient Problems Failure of Implant (1924); Pain (1994)
Event Date 07/30/2013
Event Type  Injury  
Event Description
Healthcare professional reported a "patient was seen in office for a painful [lap-band] port.Patient has lost 134+ pounds and port is beginning to protrude and needed repositioning.During surgery, [the doctor] tested port and blue dye showed back of port was leaking." the lap-band port was removed and replaced.
 
Manufacturer Narrative
Allergan has received the product however the device has not been identified nor has the analysis been completed at this time.Based upon the catalog number and implanted date provided by the reporter the connector type is assumed to be a taper ii.Pain and visibility are surgical/physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.Device labeling addresses the possible outcome of leakage as follows: "deflation of the band may occur due to leakage from the band, the port or the connector tubing." device labeling addresses the reported event of pain as follows: "there were additional occurrences of these events that were considered to be non-serious.Other adverse events considered related to the lap-band system that occurred in fewer than 1% of subjects included: abdominal pain, chest pain, incision pain and port site pain." device labeling addresses the possible outcome of visibility/palpability as follows: precautions: 6.Care must be taken to place the access port in a stable position away from areas that may be affected by significant weight loss, physical activity, or subsequent surgery.Failure to do so may result in the inability to perform percutaneous band adjustments.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LAP-BAND AP ADJUSTABLE GASTRIC BANDING SYSTEM (STANDARD)
Manufacturer (Section D)
ALLERGAN
la aurora de heredia
CS 
Manufacturer Contact
karen herrera
71 south los carneros road
goleta, CA 93117
8059615867
MDR Report Key3720620
MDR Text Key4267806
Report Number2024601-2014-00129
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 02/26/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberB-2240
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer03/10/2014
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/26/2014
Initial Date FDA Received03/20/2014
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
-
-